Hodgkin lymphoma trials in Czechia
7 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 Nov 2026. Ask the study team whether a trial fits you.
Phase 1/2RecruitingResearch participation
A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of Glofitamab in Monotherapy and in Combination with Chemoimmunotherapy in Pediatric and Young Adult Participants with Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma
- Where
- Prague
- Age
- Up to 17 years
- People
- 37 worldwide
- Run by
- F. Hoffmann-La Roche AG
See details and how to join2023-504264-41-00EU 2023-504264-41-00Registry updated 2026-11-04
No phaseRecruitingResearch participation
Early Detection and Screening of Hematological Malignancies - SANGUINE
- Where
- Olomouc
- Age
- 18 years and over
- People
- 3,000 worldwide
- Run by
- JaxBio Ltd
See details and how to joinNCT05735704Registry updated 2026-10-15
Phase 3RecruitingTrial-stage medicine
A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Secondary Antibody Deficiency Associated With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma
- Where
- Ostrava, Plzen 23, Praha 10
- Age
- 18 years and over
- People
- 49 worldwide
- Run by
- Grifols Biologicals, LLC
See details and how to joinNCT07582432EU 2026-526803-31-00Registry updated 2026-10-01
Phase 1RecruitingResearch participation
A Phase 1b Open-Label Study to Evaluate the Safety and Anti-cancer Activity of Loncastuximab Tesirine in Combination with Other Anti-cancer Agents in Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (LOTIS-7)
- Where
- Ostrava, Prague, Prague 10
- Age
- 18 years and over
- People
- 121 worldwide
- Run by
- ADC Therapeutics SA
See details and how to joinNCT04970901EU 2024-512089-32-00Registry updated 2026-09-15
Phase 3RecruitingResearch participation
A trial to learn how effective and safe odronextamab is compared to standard of care for adult participants with previously treated aggressive B-cell Non-Hodgkin Lymphoma.
- Where
- Prague 10
- Age
- 18 years and over
- People
- 132 worldwide
- Run by
- Regeneron Pharmaceuticals Inc.
See details and how to joinNCT06230224EU 2022-502783-21-00Registry updated 2026-05-25
Phase 1RecruitingTrial-stage medicine
CART19 Cells Effects in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Non-Hodgkin's Lymphoma
- Where
- Prague
- Age
- 18 years to 80 years
- People
- 10
- Run by
- Institute of Hematology and Blood Transfusion, Czech Republic
See details and how to joinNCT05054257EU 2024-510815-30-00Registry updated 2025-01-06
No phaseRecruitingResearch participation
Prognostic Significance of ctDNA in HL
- Where
- Hradec Králové, Olomouc, Prague
- Age
- 18 years and over
- People
- 500
- Run by
- Interni hematologicka klinika FNKV
See details and how to joinNCT06263530Registry updated 2024-02-16
All Hodgkin lymphoma trials and the map
This page is not medical advice. Talk to your doctor before contacting a trial.